best digital health platforms with glp-1 coverage options in Employer Plans Could Nearly Double in 2024 Medicare GLP-1 Program Eligibility: Best

By using 18 F-FDG as a contrast agent, PET-CT technology was used to reflect changes in body metabolism through the uptake of the contrast agent by the lesion, where 18 F-FDG is a glucose analog that indicates the degree of glucose uptake and is generally used clinically to quantify tissue metabolism (Paydary et al., 2019)

We generally recommend patients wait until their weight has been stable for 46 weeks to ensure the most predictable results

Patients expecting immediate energy surges or appetite suppression similar to stimulants will be disappointed

Likely not for endometriosis specifically, since these medications are not approved for this indication

10.3389/fnut.2022.790250 69